Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Pfizer Agrees To Roll Back Prices On 40 Drugs, Yielding To Pressure From Trump
Jul 11 2018
•
By
Jessica Merrill
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Pricing Debate
More from Market Access